December 28, 2010
For decades, lupus has been a challenging disease with little clinical progress. An investigational drug called Benlysta claims to offer hope for patients with systemic lupus erythematosus, if approved. With successful pivotal Phase 3 trials, University of Miami Miller School of Medicine expert Carlos Lozada, M.D., associate professor of clinical medicine, discusses the strengths and limitations of the trials and possible safety concerns. He is joined by Stacy Ardoin, M.D., assistant professor of clinical immunology and rheumatology at Ohio State University College of medicine.
Watch Dr. Lozada discuss the clinical trials »
December 21, 2010
Using surrogate markers to diagnose Alzheimer’s in young patients decades before the onset of dementia symptoms is a practice that has received considerable mainstream press. In the clip, UHealth’s Richard Isaacson, M.D., assistant professor of neurology and medicine, explains how these new markers will change the face of current therapy, speed drug development and could increase the number of disability claims filed in the United States.
Watch Dr. Isaacson discuss Alzheimer's »
December 20, 2010
Interventional cardiologist William O’Neill, M.D., executive dean for clinical affairs and chief medical officer for UHealth, reviews several cases of alleged stent overuse that are under investigation. Dr. O’Neill explains the effect this has had on research and how it has reduced the number of stent implants. He also explains common misconceptions about indications for coronary stent use.
Watch Dr. O'Neill's discussion »
December 14, 2010
Mauricio Cohen, M.D., associate professor of medicine and director of the Cardiac Catheterization Laboratory at University of Miami Hospital, discusses his recent study on the novel anticoagulation system REG 1, which was published in the journal Circulation. If approved, the system will be a major asset in interventional procedures.
See Dr. Cohen discuss REG 1 »
December 01, 2010
In this video, W. Dalton Dietrich, Ph.D., scientific director of The Miami Project to Cure Paralysis, examines two therapies to treat acute spinal cord injury. First, he discusses the use of stem cells to treat spinal cord injury, a recent trial backed by the FDA and the first human trial of its kind in the U.S. In the second half, Dr. Dietrich talks about the Miller School’s groundbreaking hypothermia treatment for acute spinal cord injury.
Watch Dr. Dietrich examine the latest in acute spinal cord injury treatment »